The Akt-mTOR tango and its relevance to cancer
Top Cited Papers
Open Access
- 1 September 2005
- journal article
- review article
- Published by Elsevier in Cancer Cell
- Vol. 8 (3), 179-183
- https://doi.org/10.1016/j.ccr.2005.08.008
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Genetic analysis of Pten and Tsc2 functional interactions in the mouse reveals asymmetrical haploinsufficiency in tumor suppressionGenes & Development, 2005
- Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR ComplexScience, 2005
- Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitiveNature Cell Biology, 2004
- Survival signalling by Akt and eIF4E in oncogenesis and cancer therapyNature, 2004
- Pten Dose Dictates Cancer Progression in the ProstatePLoS Biology, 2003
- PTEN: One Gene, Many SyndromesHuman Mutation, 2003
- Targeting RAS signalling pathways in cancer therapyNature Reviews Cancer, 2003
- dS6K-regulated cell growth is dPKB/dPI(3)K-independent, but requires dPDK1Nature Cell Biology, 2002
- Mutation ofPten/Mmac1in mice causes neoplasia in multiple organ systemsProceedings of the National Academy of Sciences, 1999
- High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in miceCurrent Biology, 1998